REGN Filing
10-QFiling Date: Apr 29, 2026

REGENERON PHARMACEUTICALS, INC. (REGN) · Quarterly Report (10-Q) SEC Filing

regn-20260331

descriptionView SEC Filing
ACC: 0000872589-26-000016open_in_new
Key Financial Metrics3M Mar'26 · 2026-03-31
Revenue$3.61B
Net Income$727.2M
Total Assets$40.87B
Stockholders' Equity$36.42B
Operating Cash Flow$1.08B

keid AI analysis is for reference only and does not constitute investment advice.